STRS Ohio’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-7,600
| Closed | -$291K | – | 2079 |
|
|
2023
Q2 | $291K | Sell |
7,600
-6,300
| -45% | -$162K | ﹤0.01% | 1492 |
|
|
2023
Q1 | $321K | Hold |
13,900
| – | – | ﹤0.01% | 1483 |
|
|
2022
Q4 | $364K | Hold |
13,900
| – | – | ﹤0.01% | 1435 |
|
|
2022
Q3 | $273K | Buy |
13,900
+9,800
| +239% | +$197K | ﹤0.01% | 1517 |
|
|
2022
Q2 | $71K | Buy |
+4,100
| New | +$64.4K | ﹤0.01% | 1820 |
|
|
2021
Q3 | – | Sell |
-7,300
| Closed | -$103K | – | 2354 |
|
|
2021
Q2 | $103K | Buy |
7,300
+4,100
| +128% | +$65.6K | ﹤0.01% | 1975 |
|
|
2021
Q1 | $49K | Hold |
3,200
| – | – | ﹤0.01% | 2029 |
|
|
2020
Q4 | $50K | Buy |
+3,200
| New | +$48.3K | ﹤0.01% | 1997 |
|
|
2020
Q3 | – | Sell |
-5,160
| Closed | -$59K | – | 2307 |
|
|
2020
Q2 | $59K | Buy |
+5,160
| New | +$71.1K | ﹤0.01% | 1881 |
|
|
2016
Q1 | – | Sell |
-4,080
| Closed | -$330K | – | 1941 |
|
|
2015
Q4 | $574K | Buy |
4,080
+3,540
| +656% | +$481K | ﹤0.01% | 1221 |
|
|
2015
Q3 | $52K | Hold |
540
| – | – | ﹤0.01% | 1758 |
|
|
2015
Q2 | $81K | Buy |
+540
| New | +$89.2K | ﹤0.01% | 1707 |
|
STRS Ohio's KDNY Position: Q3 2023 in Review
STRS Ohio sold out of Chinook Therapeutics, Inc. Common Stock (KDNY) in Q3 2023, closing a stake of 7,600 shares — an estimated $291K sold.
STRS Ohio first reported a position in KDNY in Q2 2015 and held it in 12 quarters. The position peaked at $574K in Q4 2015. 2 funds tracked by Wall St. Rank hold KDNY as of Q3 2023.
- STRS Ohio reported no remaining Chinook Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
- STRS Ohio sold 7,600 Chinook Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $291K.
- STRS Ohio first reported a position in Chinook Therapeutics, Inc. Common Stock in Q2 2015 and held it in 12 quarters.
- STRS Ohio's Chinook Therapeutics, Inc. Common Stock position peaked at $574K in Q4 2015.
- 2 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q3 2023.
Based on STRS Ohio's 13F filing for Q3 2023, filed 26 Oct 2023.